Kamala Harris' COVID-19 being treated by Paxlovid: All you need to know about Pfizer's oral drug
2 years, 7 months ago

Kamala Harris' COVID-19 being treated by Paxlovid: All you need to know about Pfizer's oral drug

Firstpost  

Paxlovid, the oral drug, reduces the risk of COVID-19-associated hospitalisation or death by 89 per cent in those who receive treatment within three days of symptom onset The fight against coronavirus received yet another boost last Friday when the World Health Organization “strongly recommended” Pfizer’s COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation. The WHO’s experts said in the BMJ medical journal that the United States’ pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with COVID-19. An interim analysis showed that Paxlovid reduced the risk of COVID-19-associated hospitalisation or death by 89 per cent in those who received treatment within three days of symptom onset. Paxlovid in India In March, the Medicines Patent Pool had signed a licence agreement with 35 generic drug makers to manufacture the generic version of Pfizer’s oral COVID-19 treatment.

India Patients Risk Covid Pfizer Paxlovid 89 Per Cent Oral Drug  kamala  covid19  paxlovid  studies  harris  risk  know  patients  pharma  received  india  oral  drug  treatment  treated  need  pfizers

History of this topic

COVID-19 treatments to enter the market with a hefty price tag
1 year, 1 month ago

COVID-19 treatments to enter the market with a hefty price tag

Associated Press  

WASHINGTON — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week. “Pfizer is committed to a smooth commercial transition and is working collaboratively with the U.S. …

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
1 year, 6 months ago

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Associated Press  

WASHINGTON — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. The FDA granted full approval for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death. Paxlovid is the fourth drug for COVID-19 to receive full FDA approval and the first one …

Pfizer’s New Oral Anti-Viral Drug Lowers Risk of Post-Covid Condition, Study Shows
1 year, 8 months ago

Pfizer’s New Oral Anti-Viral Drug Lowers Risk of Post-Covid Condition, Study Shows

News 18  

Pfizer’s oral anti-viral drug, Paxlovid, shortly after Covid-19 infection is likely to reduce the risk of developing long Covid, a new study found. The study titled ‘Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition’ found that Nirmatrelvir – sold under the brand name Paxlovid, was associated with 26% less risk of post Covid-19 condition, 47% less risk …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Firstpost  

Washington: Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several lingering …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

LA Times  

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisors Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. Pfizer originally studied Paxlovid in the highest-risk COVID-19 patients: unvaccinated adults with other health …

‘Fake’ Indian COVID-19 medicines flood China’s black market amid surge in cases
1 year, 11 months ago

‘Fake’ Indian COVID-19 medicines flood China’s black market amid surge in cases

The Hindu  

Chinese health experts are warning that fake versions of Indian generic medicines are flooding the black market in China as a record surge of COVID-19 cases fuels demand for antivirals, particularly Pfizer’s Paxlovid and Indian generic versions. With Paxlovid in short supply and highly regulated in government clinics, sales of Indian generic versions have ballooned through Chinese e-commerce platforms in …

Chinese turning to Indian drugs on black market amid Covid spike
1 year, 11 months ago

Chinese turning to Indian drugs on black market amid Covid spike

India Today  

Chinese nations have now turned to the black market for generic Covid-19 drugs as the country is dealing with an unprecedented outbreak with limited supplies of approved antivirals. China approved two Covid-19 antivirals this year - Pfizer’s Paxlovid and Azvudine, an HIV drug from Chinese firm Genuine Biotech. Topics like “anti-Covid Indian generic drugs sold at 1,000 yuan per box” …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move
1 year, 11 months ago

Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move

Firstpost  

China has been reluctant to take medicines and vaccines from the West. The oral antiviral has proved to cut the risk of hospitalisation and death The recent surge in COVID-19 cases has caused China’s healthcare infrastructure to crumble. Beijing will begin distributing American pharma giant Pfizer’s drug, Paxlovid, to community health centres in the city, according to a report by …

Hetero emerges first to get WHO Prequalification for Covid drug Nirmacom
1 year, 11 months ago

Hetero emerges first to get WHO Prequalification for Covid drug Nirmacom

Deccan Chronicle  

NEW DELHI: Pharmaceuticals firm Hetero on Monday said it has received World Health Organisation Prequalification of medicines program approval for its generic version of COVID-19 oral antiviral treatment candidate 'Nirmatrelvir'. Hetero's 'NIRMACOM', a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID', is co-packaged with ritonavir tablets, the company said in a statement. "We are committed to making NIRMACOM available …

Antiviral Covid treatment now available in the Netherlands for €1,250
2 years ago

Antiviral Covid treatment now available in the Netherlands for €1,250

NL Times  

The antiviral medication approved to treat Covid-19 is now available on the Dutch market, the Dutch Association of General Practitioners confirmed on Thursday. Treatment using the drug Paxlovid, produced by Pfizer, will cost 1,242 euros, and there are strict rules about who qualifies to get those costs covered by insurers. Two 150-milligram tablets of Paxlovid and one 100-milligram tablet of …

Pfizer CEO tests positive for COVID-19, has mild symptoms
2 years, 4 months ago

Pfizer CEO tests positive for COVID-19, has mild symptoms

LA Times  

Albert Bourla, chief executive officer of Pfizer, speaks at the World Economic Forum in Davos, Switzerland, in May. Bourla said Monday that he has a very mild case of COVID-19 and has started taking Pfizer’s Paxlovid pill. The top executive at Pfizer, a leading producer of COVID-19 vaccines and medicines, has tested positive for the virus and says he is …

Oral pill for COVID-19 approved by regulator
2 years, 4 months ago

Oral pill for COVID-19 approved by regulator

China Daily  

China Daily| Updated :2022-07-29 China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus. Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients …

Zenara Pharma gets CDSCO nod to make copy of Pfizer’s Paxlovid
2 years, 4 months ago

Zenara Pharma gets CDSCO nod to make copy of Pfizer’s Paxlovid

The Hindu  

Hyderabad-based Zenara Pharma has received Central Drugs Standard Control Organization approval to manufacture and market a generic version of Pfizer’s COVID drug Paxlovid. The product will be sold under the brand name Paxzen and being manufactured at the company’s USFDA approved facility in Hyderabad, Zenara said on Thursday. We believe Paxzen is an extremely effective treatment option against COVID-19 and, …

US allows pharmacists to prescribe Pfizer’s COVID-19 pill
2 years, 5 months ago

US allows pharmacists to prescribe Pfizer’s COVID-19 pill

Associated Press  

WASHINGTON — Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that’s intended to expand use of Pfizer’s drug Paxlovid. The Food and Drug Administration said pharmacists can begin screening patients to see if they are eligible for Paxlovid and then prescribe the medication, which has been shown to curb the worst …

FDA allows pharmacists to prescribe Pfizer’s Paxlovid COVID pill
2 years, 5 months ago

FDA allows pharmacists to prescribe Pfizer’s Paxlovid COVID pill

LA Times  

The Food and Drug Administration said Wednesday that pharmacists could now prescribe Pfizer’s Paxlovid pill directly to COVID-19 patients. Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that’s intended to expand use of Pfizer’s drug Paxlovid. The Food and Drug Administration said pharmacists can begin screening patients to see if they …

Pfizer to offer low-cost medicines, vaccines to poor nations
2 years, 6 months ago

Pfizer to offer low-cost medicines, vaccines to poor nations

Associated Press  

Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries. The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. “What we discovered through …

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill
2 years, 7 months ago

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill

Huff Post  

FILE - In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. via Associated Press WASHINGTON — As more doctors …

White House expands access to life-saving COVID-19 drug Paxlovid
2 years, 7 months ago

White House expands access to life-saving COVID-19 drug Paxlovid

Salon  

The White House is making efforts to expand access to life-saving COVID drug Paxlovid, manufactured by Pfizer, which previously suffered from shortages yet which now is widely available in most parts of the country. Earlier Tuesday, newly appointed White House Coronavirus Response Coordinator Dr. Ashish Jha indicated that a persisting scarcity mentality was to blame for previous shortages. "When Paxlovid …

Why Pfizer's new drug Paxlovid raises hopes against Covid
2 years, 7 months ago

Why Pfizer's new drug Paxlovid raises hopes against Covid

India Today  

As Covid cases in India continue to rise, a new drug from pharma major Pfizer has helped ease some of the fears. The drug has already received emergency use authorisation in the US and the UK, and has been “strongly recommended” by WHO for non-severe Covid patients who are at the highest risk of hospitalisation. However, the medication was never …

Administration expands availability of COVID antiviral pill
2 years, 7 months ago

Administration expands availability of COVID antiviral pill

Associated Press  

WASHINGTON — President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, seeking to reassure doctors that there is ample supply for people at high risk of severe illness or death from the virus. “Paxlovid will be widely available everywhere in America,” said Dr. Ashish Jha, the White House COVID-19 response coordinator. The …

Biden admin to promote availability of COVID antiviral pill
2 years, 8 months ago

Biden admin to promote availability of COVID antiviral pill

Associated Press  

WASHINGTON — President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed. A senior administration official said usage of the antiviral regimen has “more than doubled” over the last few weeks, but the administration …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?
2 years, 8 months ago

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?

News 18  

Paxlovid, Pfizer’s Covid-19 antiviral pill, has been “strongly recommended” by the World Health Organization for patients with milder forms of the disease who are still at high risk of hospitalisation. WHO experts have said that Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respect to harms than Molnupiravir, and is easier to administer than …

WHO 'strongly recommends' Pfizer's Covid pill | 5 things to know about Paxlovid
2 years, 8 months ago

WHO 'strongly recommends' Pfizer's Covid pill | 5 things to know about Paxlovid

Hindustan Times  

The World Health Organization on Friday “strongly recommended” the use of Pfizer's antiviral pill Paxlovid in patients with mild and moderate forms of coronavirus disease at the highest risk of hospitalisation. 5 things you need to know about Pfizer's antiviral pill: Paxlovid is a combination of nirmatrelvir and ritonavir tablets and is administered orally. While the brand name drug, sold …

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan
2 years, 10 months ago

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan

Live Mint  

TOKYO : Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s Paxlovid. Pfizer said its final-stage trial, which included more than 2,000 patients, showed Paxlovid cut the risk of hospitalization or …

Opinion | Covid cases spiralling: Exercise utmost caution
2 years, 11 months ago

Opinion | Covid cases spiralling: Exercise utmost caution

India TV News  

With the spread of Covid pandemic across India remaining unabated, the Centre has given approval for emergency use of anti-viral drug Molnupiravir with some specific conditions and restrictions. The authorities in the US have also allowed the use of another drug Paxlovid, made by Pfizer for use on Covid patients. On Tuesday, more than 1.68 lakh new Covid cases were …

Pfizer’s Covid-19 antiviral pill was hailed as a game-changer, but supplies are scarce
2 years, 11 months ago

Pfizer’s Covid-19 antiviral pill was hailed as a game-changer, but supplies are scarce

CNN  

CNN — The Omicron variant of the coronavirus is causing Covid-19 cases to spike, with an average of more than 747,000 new cases a day, according to the latest numbers from Johns Hopkins University. “We’re using these medications judiciously and really giving them to the people that would most benefit from these therapeutics,” Dhanireddy said. I think the whole idea …

Optimus Pharma to launch anti-COVID pill Molnupiravir next week; all you need to know
2 years, 11 months ago

Optimus Pharma to launch anti-COVID pill Molnupiravir next week; all you need to know

Firstpost  

Molnupiravir, developed by US-based biotechnology company Ridgeback Biotherapeutics in collaboration with US pharma giant Merck, was approved for emergency use in India on Tuesday The Drug Controller General of India had earlier this week approved Molnupiravir for restricted use in an emergency situation in India. Brinton Pharmaceuticals on Thursday said it will launch its generic version of anti-COVID-19 pill Molnupiravir …

2 more Covid vaccines Covovax and Corbevax, and anti-viral drug Molnupiravir cleared for use in India
2 years, 11 months ago

2 more Covid vaccines Covovax and Corbevax, and anti-viral drug Molnupiravir cleared for use in India

India TV News  

Covovax, Corbevax vaccine latest news: The Government has approved two more Covid vaccines and an anti-viral drug for use in India. Health Minister Dr. Mansukh Mandaviya said that the Central Drugs Standard Control Organisation under the Ministry of Health and Family Welfare has given emergency use authorization approval to COVID-19 vaccines Covovax and Corbevax and Anti-viral drug Molnupiravir. "CORBEVAX vaccine …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world
3 years ago

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world

Deccan Chronicle  

On December 22, the US Food and Drugs Administration approved an oral Covid-19 drug Paxlovid. This understanding has practical relevance in Covid-19 clinical management, that the antiviral drugs work better in the first phase and the immunomodulators, immunosuppressive/anti-inflammatory drugs in the later phase. Nearly all currently available Covid-19 drugs need to be given either intravenously or through injections, in hospital …

Pfizer's oral Covid-19 pill gets US authorisation for at-home use
3 years ago

Pfizer's oral Covid-19 pill gets US authorisation for at-home use

India TV News  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment
3 years ago

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment

News 18  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

Pfizer pill becomes 1st U.S.-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st U.S.-authorized home COVID treatment

LA Times  

Americans will be able to take a pill by Pfizer at home to head off the worst effects of the coronavirus. U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the coronavirus. But Pfizer’s drug is all but certain …

European Medicines Agency recommends emergency use of Pfizer Covid-19 pill
3 years ago

European Medicines Agency recommends emergency use of Pfizer Covid-19 pill

India TV News  

Highlights Paxlovid should be administered as soon as possible after diagnosis of Covid-19. The European Medicines Agency has issued advice on the emergency use of Pfizer's Covid-19 pill called Paxlovid. EMA said it issued this advice to support national authorities who may decide on possible early use of the medicine prior to marketing authorization, for example in emergency use settings, …

As Omicron peaks, here's the status of 3 Covid-19 drugs Molnupiravir, Paxlovid and Ronapreve
3 years ago

As Omicron peaks, here's the status of 3 Covid-19 drugs Molnupiravir, Paxlovid and Ronapreve

India Today  

On Friday, Delhi Health Minister Satyendar Jain said 10 new cases of the new coronavirus variant, Omicron, have been detected in the national capital, taking the tally to 20. Pfizer said earlier this week that Paxlovid appears effective against the new Omicron variant. Availability in India and world The European Union drug regulator issued advice, earlier this week, on the …

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’
3 years ago

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’

CNN  

Washington CNN — President Joe Biden on Tuesday praised Pfizer’s report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms. “I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective at reducing the …

Merck’s covid-19 pill backed by FDA advisers
3 years ago

Merck’s covid-19 pill backed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Several panel members who voted in favor of authorization said use of molnupiravir should be limited to unvaccinated people at high risk of Covid-19 complications, and that while more …

Merck’s covid-19 pill to be reviewed by FDA advisers
3 years ago

Merck’s covid-19 pill to be reviewed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Researchers plan to study molnupiravir and Omicron soon but think the drug could be effective because it has been found to work against other Covid-19 variants, the …

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir
3 years, 1 month ago

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir

India Today  

Vaccines have been the primary antidote in the battle against Covid-19 to date, but we could have at least two game-changers in the form of American pharmaceutical giant Pfizer's antiviral pill Paxlovid, and Molnupiravir, manufactured by Merck, Sharp and Dohme, and Ridgeback Biotherapeutics. The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease …

MSD in talks to give additional licences for molnupiravir
3 years, 5 months ago

MSD in talks to give additional licences for molnupiravir

Live Mint  

Merck Sharp & Dohme is in talks with several Indian drug manufacturers to give voluntary licences for its investigational covid-19 treatment molnupiravir and also aims to participate in United Nations-backed Medicines Patents Pool through which it can increase access to the drug, MSD India managing director Rehan A. Khan said. “The company has had discussions with a number of established …

Pfizer in final stages to get nod for covid vaccine in India: CEO Albert Bourla
3 years, 6 months ago

Pfizer in final stages to get nod for covid vaccine in India: CEO Albert Bourla

Live Mint  

Pharmaceutical company Pfizer is now in final stages to get approval for its Covid-19 vaccine in India, the company's CEO Albert Bourla said as reported by news agency ANI. Speaking at a virtual event, Pfizer Chief Executive Officer Albert Bourla said he hopes the company will finalize an agreement with the Indian government soon. I hope very soon we will …

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla
3 years, 6 months ago

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla

India Today  

Pfizer is now in the final stages of getting emergency use approval for its Covid-19 vaccine in India, said the company's Chairman and CEO, Albert Bourla. READ: Pfizer to test Covid-19 vaccine in larger group of children below 12 NITI Aayog member Dr VK Paul told CNBC-TV18 on Monday that the central government is in talks with Pfizer and other …

Told India no safety concern with its Covid-19 vaccine: Pfizer
3 years, 7 months ago

Told India no safety concern with its Covid-19 vaccine: Pfizer

India Today  

Pfizer Inc said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses. The government in mid-April made it easier for foreign vaccines approved in the West and Japan to …

Discussions on with Indian govt for expedited approval of COVID-19 vaccine: Pfizer
3 years, 7 months ago

Discussions on with Indian govt for expedited approval of COVID-19 vaccine: Pfizer

India TV News  

Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company's Chairman and CEO Albert Bourla said on Monday. We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country," Bourla said in …

Coronavirus | Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
4 years ago

Coronavirus | Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

The Hindu  

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain. “Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine …

Pfizer seeks emergency use authorisation of its COVID-19 vaccine in India
4 years ago

Pfizer seeks emergency use authorisation of its COVID-19 vaccine in India

Firstpost  

In its application to the Drugs Controller General of India, Pfizer has sought permission to import the vaccine for sale and distribution in India, as per official sources New Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country after its …

Discover Related